Company profile

BioVersys AG insider transactions

BIOVER

Management transactions

4

Shareholding disclosures

15

First disclosure

13.02.2025

Last disclosure

14.05.2026

Company summary

No management purchase or sale disclosed in the last 90 days.

Latest purchase
CHF 1’839

14.05.2026 · Non-executive member of the board of directors

Net flow 90 d
CHF 0.00

Buys − sales

Top shareholder
5.686%

UBS Fund Management Switzerland AG

This page brings together all BioVersys AG (BIOVER) insider transactions: 4 management transactions and 15 significant shareholding disclosures published by SIX Exchange Regulation, from 13.02.2025 to 14.05.2026.

Detailed context

The insider24.ch page for BioVersys AG provides an overview of insider transactions and significant shareholding disclosures published by SIX Exchange Regulation. To date, there have been 4 management transactions and 15 significant shareholding disclosures reported, with the latest management transaction recorded on 2026-05-14. During the last 90 days, there were 0 purchases totaling CHF 0 and 0 sales totaling CHF 0. The largest declared shareholders by voting rights include UBS Fund Management Switzerland AG at 5.686%, BioVersys AG at 5.038%, Candriam at 3.91%, and ViaValor AG at 3.434%.

Insider barometer

90 days

No transaction in this window

Latest transaction

14.05.2026

Largest purchase

CHF 1’839

Largest sale

—

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow BioVersys AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

BioVersys AG insider transactions

Latest shareholding disclosures